Fatty acid synthase drives the synthesis of phospholipids partitioning into detergent-resistant membrane microdomains

被引:209
作者
Swinnen, JV
Van Veldhoven, PP
Timmermans, L
De Schrijver, E
Brusselmans, K
Vanderhoydonc, F
Van de Sande, T
Heemers, H
Heyns, W
Verhoeven, G
机构
[1] Catholic Univ Louvain, Lab Expt Med & Endocrinol, LEGENDO, Gasthuisberg, B-3000 Louvain, Belgium
[2] Catholic Univ Louvain, Dept Pharmacol, Gasthuisberg, B-3000 Louvain, Belgium
关键词
fatty acid synthase; raft; microdomain; DRM; lipogenesis; LNCaP; cancer;
D O I
10.1016/S0006-291X(03)00265-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fatty acid synthase (FAS) is a key metabolic enzyme catalyzing the synthesis of long-chain saturated fatty acids. It plays a central role in the production of surfactant in fetal lungs, in the supply of fatty components of milk, and in the conversion and storage of energy in liver and adipose tissue. Remarkably high levels of FAS expression are found in the majority of human epithelial cancers. As the role of FAS in cancer cells remains largely unknown, we have initiated studies to assess the fate of newly synthesized lipids in cancer cells and have estimated the contribution of FAS to the synthesis of specific lipid classes by treating the cells with small interfering RNAs targeting FAS. Here, we show that in cancer cells FAS plays a major role in the synthesis of phospholipids partitioning into detergent-resistant membrane microdomains. These are raft-aggregates implicated in key cellular processes including signal transduction, intracellular trafficking, cell polarization, and cell migration. These findings reveal a novel role for FAS, provide important new insights into the otherwise poorly understood mechanisms underlying the control of lipid composition of membrane microdomains, and point to a link between FAS overexpression and dysregulation of membrane composition and functioning in tumor cells. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:898 / 903
页数:6
相关论文
共 25 条
  • [11] Retention of prominin in microvilli reveals distinct cholesterol-based lipid micro-domains in the apical plasma membrane
    Röper, K
    Corbeil, D
    Huttner, WB
    [J]. NATURE CELL BIOLOGY, 2000, 2 (09) : 582 - 592
  • [12] Metabolic labelling of membrane microdomains/rafts in Jurkat cells indicates the presence of glycerophospholipids implicated in signal transduction by the CD3 T-cell receptor
    Rouquette-Jazdanian, AK
    Pelassy, C
    Breittmayer, JP
    Cousin, JL
    Aussel, C
    [J]. BIOCHEMICAL JOURNAL, 2002, 363 (03) : 645 - 655
  • [13] Lipid rafts and signal transduction
    Simons, K
    Toomre, D
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2000, 1 (01) : 31 - 39
  • [14] Fumonisin B-1-induced sphingolipid depletion inhibits vitamin uptake via the glycosylphosphatidylinositol-anchored folate receptor
    Stevens, VL
    Tang, JH
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (29) : 18020 - 18025
  • [15] Stimulation of tumor-associated fatty acid synthase expression by growth factor activation of the sterol regulatory element-binding protein pathway
    Swinnen, JV
    Heemers, H
    Deboel, L
    Foufelle, F
    Heyns, W
    Verhoeven, G
    [J]. ONCOGENE, 2000, 19 (45) : 5173 - 5181
  • [16] Coordinate regulation of lipogenic gene expression by androgens: Evidence for a cascade mechanism involving sterol regulatory element binding proteins
    Swinnen, JV
    Ulrix, W
    Heyns, W
    Verhoeven, G
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (24) : 12975 - 12980
  • [17] Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer
    Swinnen, JV
    Roskams, T
    Joniau, S
    Van Poppel, H
    Oyen, R
    Baert, L
    Heyns, W
    Verhoeven, G
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2002, 98 (01) : 19 - 22
  • [18] Androgens markedly stimulate the accumulation of neutral lipids in the human prostatic adenocarcinoma cell line LNCaP
    Swinnen, JV
    VanVeldhoven, PP
    Esquenet, M
    Heyns, W
    Verhoeven, G
    [J]. ENDOCRINOLOGY, 1996, 137 (10) : 4468 - 4474
  • [19] Swinnen JV, 1997, CANCER RES, V57, P1086
  • [20] Van de Sande T, 2002, CANCER RES, V62, P642